Strategic review continues at Elixinol as management mull sale or merger by Steve Jones May 4, 2022May 4, 2022 Selling individual business units, or even the company as a whole, remain on the table for […]
Company news: Cronos; ECS Botanics; Elixinol; Zelira; Medlab; Emyria; Creso; MGC Pharma; Botanix; Incannex by Martin Lane February 2, 2022February 2, 2022
Company news: Rua Bioscience; Elixinol; Emyria; Cann Global; Health House; New Zealand Natural Fibres by Martin Lane December 22, 2021December 22, 2021
Company news: Cann Group; Releaf Group; Elixinol Wellness; Cronos Australia; Auscann; Zelira; Emyria; Incannex by cannabiz team October 21, 2021October 21, 2021
Company news: TCann; ECS Botanics; Cannaponics; Releaf Group; Cannvalate; Elixinol; Creso Pharma; Incannex by Martin Lane August 19, 2021August 19, 2021
Elixinol Wellness to refocus on Australian market after Q2 revenue spike by Martin Lane July 22, 2021July 22, 2021
Elixinol Global AGM approves rebrand to Elixinol Wellness; key appointments confirmed by Martin Lane May 17, 2021May 18, 2021
Company news: Elixinol Global; Bod Australia; MGC Pharma; Cronos Australia; Epsilon Healthcare by Martin Lane April 23, 2021April 29, 2021
